Upregulation of angiotensin signalling pathways underlies the increased contractility observed in pulmonary fibrosis lung fibroblasts
Dietmar Abraham(Medical University of Vienna), Mark Eastwood, M Dusmet, Shiwen Xu(Northeast Agricultural University), Adrian Wells(National Health Service), CP Denton(The Royal Free Hospital), Andrew Leask(University of Saskatchewan), Toby M. Maher(University of Southern California)
UCL Discovery (University College London)
September 1, 2010
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Pulmonary fibrosis secondary to COVID-19: a call to arms?
|The Lancet Respiratory Medicine|2020|498
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
Connective Tissue Growth Factor Gene Regulation
|Journal of Biological Chemistry|2003|301